Posted on December 16, 2019 by Is Tasigna (Or Nilotinib) Worth Testing For Parkinson’s? : Shots – Health News – NPR Is Tasigna (Or Nilotinib) Worth Testing For Parkinson’s? : Shots – Health News NPR How Novartis’ cancer drug Tasigna restores critical dopamine that’s lost to Parkinson’s disease FierceBiotech View full coverage on Google News
